19.12.2012 Views

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) I.1(1)<br />

TUNGEN ZUR PROPHYLAXE VON SCHÄ-<br />

DEN AN DER HAUTEIGENEN DNA UND/<br />

ODER ZUR REPARATUR BEREITS EINGE-<br />

TRETENER SCHÄDEN AN DER HAUT-<br />

EIGENEN DNA<br />

USE OF GLYCYRRHETIC ACID AND/OR<br />

DERIVATIVES THEREOF FOR THE<br />

PRODUCTION OF COSMETIC OR DERMA-<br />

TOLOGICAL PREPARATIONS FOR THE<br />

PROPHYLAXIS OF DAMAGE TO SKIN<br />

DNA AND/OR FOR REPAIRING<br />

PREVIOUSLY INCURRED DAMAGED TO<br />

SKIN DNA<br />

UTILISATION D'ACIDE GLYCYRRHÉTI-<br />

NIQUE ET/OU DE SES DÉRIVÉS POUR<br />

PRODUIRE DES COMPOSITIONS COSMÉ-<br />

TIQUES OU DERMATOLOGIQUES PRÉVE-<br />

NANT LES DOMMAGES DE L'ADN DE LA<br />

PEAU ET/OU RÉPARANT DES<br />

DOMMAGES DÉJÀ SUBIS PAR L'ADN DE<br />

LA PEAU<br />

(71) Beiersdorf AG, Unnastrasse 48, 20253 Hamburg,<br />

DE<br />

(72) KOLBE, Ludger, 21255 Dohren, DE<br />

SCHERNER, Cathrin, 22851 Norderstedt, DE<br />

MANN, Tobias, 22175 Hamburg, DE<br />

AHLHEIT, Sabrina, 22303 Hamburg, DE<br />

HONG, Michael, 10789 Berlin, DE<br />

A61K 8/64 → (51) C07K 5/08<br />

A61K 8/73 → (51) A61K 8/06<br />

A61K 8/81 → (51) A61K 8/23<br />

A61K 8/88 → (51) A61K 8/04<br />

A61K 8/90 → (51) A61K 8/06<br />

A61K 8/92 → (51) A61K 8/06<br />

(51) A61K 9/00 (11) 2 421 503 A1*<br />

A61K 9/12 A61K 31/335<br />

(25) En (26) En<br />

(21) 10715336.3 (22) 23.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) GB 2010/050671 23.04.2010<br />

(87) WO 2010/122355 2010/43 28.10.2010<br />

(30) 23.04.20<strong>09</strong> GB <strong>09</strong>06977<br />

23.04.20<strong>09</strong> PCT/GB20<strong>09</strong>/050416<br />

(54) SUBLINGUALE PHARMAZEUTISCHE ZU-<br />

SAMMENSETZUNG MIT EINEM NEUTRA-<br />

LEN ÖL<br />

SUBLINGUAL PHARMACEUTICAL<br />

COMPOSITION COMPRISING A NEUTRAL<br />

OIL<br />

COMPOSITION PHARMACEUTIQUE<br />

SUBLINGUALE COMPRENANT UNE<br />

HUILE NEUTRE<br />

(71) Londonpharma Ltd., Norwich Bioincubator<br />

Norwich Research Park, Colney Lane,<br />

Norwich NR4 7UH, GB<br />

(72) BOOLES, Clive, Norwich Norfolk NR4 7UH,<br />

GB<br />

(74) ip21 Ltd, Central Formalities Department<br />

Lakeside 300 Old Chapel Way, Broadland<br />

Business Park Norwich Norfolk NR7 0WG,<br />

GB<br />

(51) A61K 9/00 (11) 2 421 504 A1*<br />

A61K 31/13 A61K 9/08<br />

(25) En (26) En<br />

(21) 10717263.7 (22) 12.04.2010<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) IB 2010/051573 12.04.2010<br />

(87) WO 2010/122442 2010/43 28.10.2010<br />

(30) 21.04.20<strong>09</strong> EP <strong>09</strong>290298<br />

(54) PÄDIATRISCHE LÖSUNGEN MIT EINEM<br />

BETA-BLOCKER<br />

PAEDIATRIC SOLUTIONS COMPRISING A<br />

BETA-BLOCKER<br />

SOLUTIONS PÉDIATRIQUES COMPRE-<br />

NANT UN BÉTABLOQUANT<br />

(71) Pierre Fabre Dermo-Cosmétique, 45, place<br />

Abel-Gance, 92100 Boulogne, FR<br />

(72) CHAUMONT, Christine, F-92100 Boulogne-<br />

Billancourt, FR<br />

CORDOLIANI, Jean-François, F-92100<br />

Boulogne Billancourt, FR<br />

LEVERD, Elie, F-92100 Boulogne Billancourt,<br />

FR<br />

MUGUET, Valérie, F-92100 Boulogne Billancourt,<br />

FR<br />

(74) Hirsch & Associés, 58, avenue Marceau,<br />

75008 Paris, FR<br />

A61K 9/00 → (51) A61K 31/155<br />

A61K 9/00 → (51) A61K 31/167<br />

A61K 9/00 → (51) A61K 31/422<br />

A61K 9/00 → (51) A61K 47/36<br />

(51) A61K 9/06 (11) 2 421 505 A2*<br />

A61K 47/40 A61K 47/34<br />

A61K 39/395 A61P 37/00<br />

A61P 31/00<br />

(25) En (26) En<br />

(21) 10767686.8 (22) 21.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/031866 21.04.2010<br />

(87) WO 2010/123971 2010/43 28.10.2010<br />

(88) 03.03.2011<br />

(30) 22.04.20<strong>09</strong> US 171663 P<br />

(54) HYDROGELE FÜR DIE KOMBINATORI-<br />

SCHE FREISETZUNG VON IMMUNMODU-<br />

LIERENDEN BIOMOLEKÜLEN<br />

HYDROGELS FOR COMBINATORIAL<br />

DELIVERY OF IMMUNE-MODULATING<br />

BIOMOLECULES<br />

HYDROGELS POUR ADMINISTRATION<br />

COMBINATOIRE DE BIOMOLÉCULES<br />

MODULANT L'IMMUNITÉ<br />

(71) Board of Regents, The University of Texas<br />

System, 201 West Seventh Street, Austin, TX<br />

78701, US<br />

(72) SINGH, Ankur, Austin TX 78705, US<br />

ROY, Krishnendu, Austin TX 78750, US<br />

KASTURI, Sudhir, Atlanta GA 30319, US<br />

(74) Pilkington, Stephanie Joan, Potter Clarkson<br />

LLP Park View House 58 The Ropewalk,<br />

Nottingham NG1 5DD, GB<br />

A61K 9/06 → (51) A61K 31/422<br />

A61K 9/06 → (51) A61K 38/17<br />

A61K 9/08 → (51) A61K 9/00<br />

A61K 9/08 → (51) A61K 31/495<br />

A61K 9/107 → (51) A61K 8/06<br />

A61K 9/12 → (51) A61K 9/00<br />

A61K 9/12 → (51) A61K 31/538<br />

36<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>09</strong>/<strong>2012</strong>) 29.02.<strong>2012</strong><br />

A61K 9/127 → (51) A61K 9/133<br />

(51) A61K 9/133 (11) 2 421 506 A2*<br />

A61K 9/127 A61P 35/00<br />

(25) En (26) En<br />

(21) 10767710.6 (22) 21.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2010/031914 21.04.2010<br />

(87) WO 2010/124004 2010/43 28.10.2010<br />

(88) 17.02.2011<br />

(30) 22.04.20<strong>09</strong> US 171745 P<br />

(54) NANOTRÄGERTHERAPIE ZUR BEHAND-<br />

LUNG VON INVASIVEN TUMOREN<br />

NANOCARRIER THERAPY FOR TREATING<br />

INVASIVE TUMORS<br />

THÉRAPIE PAR NANOSUPPORT POUR<br />

TRAITER DES TUMEURS INVASIVES<br />

(71) Emory University, <strong>Office</strong> of Technology<br />

Transfer 1599 Clifton Road 4th Floor,<br />

Atlanta, GA 30322, US<br />

Georgia Institute Of Technology, 505 10th<br />

Street N.W., Atlanta, GA 30332-0415, US<br />

(72) MUNSON, Jennifer, M., Atlanta GA 303<strong>09</strong>,<br />

US<br />

BELLAMKONDA, Ravi, V., Marietta GA<br />

30062, US<br />

ARBISER, Jack, L., Atlanta GA 30329, US<br />

(74) Hallybone, Huw George, Carpmaels &<br />

Ransford One Southampton Row, London<br />

WC1B 5HA, GB<br />

(51) A61K 9/14 (11) 2 421 507 A1*<br />

A61K 9/68 A61K 31/465<br />

(25) En (26) En<br />

(21) 10716463.4 (22) 26.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) DK 2010/000055 26.04.2010<br />

(87) WO 2010/121619 2010/43 28.10.2010<br />

(30) 24.04.20<strong>09</strong> US 172474 P<br />

(54) KAUGUMMI UND TEILCHENFÖRMIGES<br />

MATERIAL ZUR KONTROLLIERTEN FREI-<br />

SETZUNG VON WIRKSTOFFEN<br />

CHEWING GUM AND PARTICULATE<br />

MATERIAL FOR CONTROLLED RELEASE<br />

OF ACTIVE INGREDIENTS<br />

GOMME À MÂCHER ET MATIÈRE PARTI-<br />

CULAIRE POUR LA LIBÉRATION<br />

CONTRÔLÉE DE PRINCIPES ACTIFS<br />

(71) Fertin Pharma A/S, Dandyvej 19, 7100 Vejle,<br />

DK<br />

(72) PEDERSEN, Kurt, Møller, DK-7323 Give, DK<br />

ANDERSEN, Jette, Baek, DK-7100 Vejle, DK<br />

(74) Mikkelsen, Hans Kristian Saaby, et al,<br />

<strong>Patent</strong>gruppen A/S Arosgaarden Aaboulevarden<br />

31, 8000 Aarhus C, DK<br />

(51) A61K 9/14 (11) 2 421 508 A1*<br />

(25) En (26) En<br />

(21) 10716464.2 (22) 26.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) DK 2010/000056 26.04.2010<br />

(87) WO 2010/121620 2010/43 28.10.2010<br />

(30) 24.04.20<strong>09</strong> US 172474 P<br />

(54) PARTIKELFÖRMIGES MATERIAL ZUR<br />

VERZÖGERTEN WIRKSTOFFFREISET-<br />

ZUNG<br />

PARTICULATE MATERIAL FOR<br />

CONTROLLED RELEASE OF ACTIVE<br />

INGREDIENTS<br />

MATIÈRE PARTICULAIRE POUR LA LIBÉ-<br />

RATION CONTRÔLÉE DE PRINCIPES<br />

ACTIFS<br />

(71) Omya Development AG, Baslerstrasse 42<br />

Postfach 32, 4665 Oftringen, CH

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!